EHC Encompass Health Corp

NYSE encompasshealth.com


$ 124.60 $ 1.55 (1.26 %)    

Friday, 17-Oct-2025 15:59:59 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 124.55
$ 123.45
$ 105.58 x 1
$ 128.38 x 10
$ 123.44 - $ 124.72
$ 87.45 - $ 127.66
592,225
na
12.55B
$ 0.70
$ 24.00
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-28-2025 01-01-1970 10-K
4 11-01-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-01-2023 09-30-2023 10-Q
9 08-04-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 02-27-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 11-02-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-01-2019 03-31-2019 10-Q
27 02-27-2019 12-31-2018 10-K
28 10-31-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-28-2018 12-31-2017 10-K
32 10-31-2017 09-30-2017 10-Q
33 08-02-2017 06-30-2017 10-Q
34 04-28-2017 03-31-2017 10-Q
35 02-22-2017 12-31-2016 10-K
36 10-28-2016 09-30-2016 10-Q
37 07-29-2016 06-30-2016 10-Q
38 04-28-2016 03-31-2016 10-Q
39 02-25-2016 12-31-2015 10-K
40 10-29-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ubs-maintains-buy-on-encompass-health-raises-price-target-to-150

UBS analyst A.J. Rice maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $140 to $150.

 keybanc-maintains-overweight-on-encompass-health-raises-price-target-to-140

Keybanc analyst Matthew Gillmor maintains Encompass Health (NYSE:EHC) with a Overweight and raises the price target from $13...

 encompass-health-affirms-fy2025-adj-eps-guidance-of-512-534-vs-528-est-affirms-fy2025-sales-guidance-of-5880b-5980b-vs-5935b-est

Encompass Health (NYSE:EHC) affirms FY2025 Adj EPS guidance from $5.12-$5.34 to $5.12-$5.34 vs $5.28 analyst estimate. Affirms ...

 b-of-a-securities-maintains-buy-on-encompass-health-raises-price-target-to-160

B of A Securities analyst Kevin Fischbeck maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from ...

 encompass-health-and-bsa-health-system-enters-partnership-to-own-and-operate-rehabilitation-hospital-in-amarillo-texas

BIRMINGHAM, Ala., and AMARILLO, Texas, Aug. 15, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC), the nation's larges...

 truist-securities-maintains-buy-on-encompass-health-raises-price-target-to-140

Truist Securities analyst David Macdonald maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from ...

 ubs-maintains-buy-on-encompass-health-raises-price-target-to-140

UBS analyst Andrew Mok maintains Encompass Health (NYSE:EHC) with a Buy and raises the price target from $130 to $140.

 encompass-health-raises-fy2025-adj-eps-guidance-from-485-510-to-512-534-vs-501-est-raises-fy2025-sales-guidance-from-5850b-5925b-to-5880b-5980b-vs-5892b-est

Encompass Health (NYSE:EHC) raises FY2025 Adj EPS guidance from $4.85-$5.10 to $5.12-$5.34 vs $5.01 analyst estimate. Raises FY...

 encompass-health-q2-adj-eps-140-beats-121-estimate-sales-1458b-beat-1427b-estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.40 per share which beat the analyst consensus estimate of $1.21 b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION